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 ABSTRACT 
Cardiovascular disease (CVD) is a leading cause of death in women. Early stages of subclinical 
atherosclerosis cause functional changes to the vasculature manifesting as endothelial 
dysfunction. These early functional changes give way to structural alterations to the vessel wall 
that can lead to increased arterial stiffness and irreversible vascular remodeling, (i.e. altered 
lumen diameter and increased intima media wall thickness (IMT)) which can ultimately lead to a 
cardiac event. Chronic exercise combined with energy deficiency may lead to a lack of menses 
or amenorrhea in premenopausal women. This state is associated with endothelial dysfunction 
and is believed to be attributable to hypoestrogenic mechanisms. Whether there are further 
detrimental structural changes to the artery in exercise-trained amenorrheic women remains 
unknown. PURPOSE: The primary purpose of this study was to examine indices of endothelial 
function, arterial stiffness and vascular remodeling in exercise-trained amenorrheic women to 
gain insight into the extent and severity of subclinical atherosclerotic CVD risk in this 
population. HYPOTHESES: It was hypothesized that, exercise-trained amenorrheic women 
would have lower endothelial function, higher arterial stiffness, and unfavorable vascular 
remodeling (greater femoral IMT and smaller femoral artery diameter) compared with exercise-
trained eumenorrheic women and similar levels of endothelial dysfunction, arterial stiffness, and 
vascular remodeling compared to sedentary eumenorrheic women. METHODS: Forty-three 
women participated in this study: 10 exercise-trained amenorrheic women (Age 21 ± 3 years, 
Body Mass Index (BMI) 21.5 ± 2.0 kg/m2), 18 exercise-trained eumenorrheic women (Age 22 ± 
3 years, BMI 22.9 ± 2.4 kg/m2), and 15 sedentary eumenorrheic women (Age 23 ± 4 years, BMI 
23.9 ± 3.2 kg/m2). Flow mediated dilation (FMD) of the brachial artery was used to measure 
endothelial function. Carotid-femoral Pulse Wave Velocity (PWV) was used to measure arterial 
 stiffness. Diameters and intima media thickness (IMT) of the superficial femoral artery (SFA) 
were taken as measures of vascular remodeling, and acquired using ultrasonography.  Blood 
lipids, hematocrit, and hemoglobin were measured using a finger stick. A saliva collection was 
used to measure estradiol. Air displacement plethysmography was used to measure body fat 
percentage. Maximal oxygen uptake was used to measure maximal aerobic capacity and a 3-day 
diet record was administered to measure dietary intake. RESULTS: FMD in exercise-trained 
amenorrheic women was not significantly different from exercise-trained and sedentary 
eumenorrheic women (Amenorrheic: 7.15 ± 4.21 mm vs. Exercise-trained Eumenorrheic: 11.10 
± 4.29 mm vs. Sedentary: 0.25 ± 3.86 mm, P = 0.07). There were significant differences between 
groups in the reactive hyperemia shear rate stimulus (i.e. Area Under the Curve (AUC)), 
(Amenorrheic: 808 ± 350.1 aU vs. Exercise-trained Eumenorrheic: 862 ± 311.0 aU vs. 
Sedentary: 1096 ± 311.3 aU, P = 0.05). When FMD was normalized for the shear rate stimulus 
exercise-trained amenorrheic women had a significantly lower FMD response compared with 
eumenorrheic women (Amenorrheic: 6.91 ± 1.33mm vs. Exercise-trained Eumenorrheic: 10.97 ± 
0.98mm vs. Sedentary: 10.57 ± 1.11mm, P = 0.05). Aortic PWV in the exercise-trained 
amenorrheic group was not significantly different from the eumenorrheic groups (Amenorrheic: 
5.00 ± 1.00 m/s vs. Exercise-trained Eumenorrheic: 4.60 ± 0.50 m/s vs. Sedentary: 5.40 ± 0.80 
m/s, P = 0.03). SFA diameters were significantly higher in the exercise-trained groups compared 
with the sedentary eumenorrheic group (Amenorrheic: 5.70 ± 0.72 mm vs. Exercise-trained 
Eumenorrheic: 5.68 ± 0.70 mm vs. Sedentary: 5.10 ± 0.63 mm, P = 0.03) while IMT was 
significantly lower in the exercise-trained amenorrheic women compared with the sedentary 
eumenorrheic women  (Amenorrheic: 0.31 ± 0.03 mm vs. Exercise-trained Eumenorrheic: 0.35 ± 
0.06 mm vs. Sedentary: 0.38 ± 0.07 mm, P = 0.01). 17β-Estradiol levels in exercise-trained 
 amenorrheic women were similar to levels in eumenorrheic women (Amenorrheic: 1.66 ± 0.84 
pg/ml vs. Exercise-trained Eumenorrheic: 2.22 ± 1.17 pg/ml vs. Sedentary: 2.00 ± 0.81 pg/ml, P 
= 0.34). Blood lipid and hematological measures, and 3-day dietary record of nutrients, vitamins 
and minerals were not significantly different between groups (P > 0.05). CONCLUSIONS: 
Exercise-trained amenorrheic women had endothelial dysfunction, but did not have increased 
arterial stiffness or adverse vascular remodeling when compared to their eumenorrheic 
counterparts. This study suggests that vascular dysfunction does not extend beyond the 
endothelium, as arterial stiffness and vascular remodeling are not affected by the amenorrheic 
state.  
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Synopsis of the Current Study  
Cardiovascular disease (CVD) is a leading cause of morbidity and mortality among 
women in the United States [1]. The prevalence of CVD increases as women age and enter 
menopause [2]. Atherosclerotic CVD results in changes to the vasculature: endothelial 
dysfunction, arterial stiffness, and vascular remodeling. Each of these changes is associated with 
future cardiovascular events, such as myocardial infarction and stroke [3, 4]. Aerobic exercise 
reduces the risk for CVD [5-7] possibly by improving endothelial function and arterial stiffness 
while preventing negative vascular remodeling [8]. Chronic aerobic exercise is cardio-protective 
but when coupled with energy deficiency can be detrimental and lead to exercise-associated 
amenorrhea or lack of a menstrual cycle in exercise-trained women. Previous studies show that 
exercise-trained amenorrheic women have lower estrogen concentrations, which contribute to 
endothelial dysfunction [9-12]. Endothelial dysfunction in exercise-trained amenorrheic women 
is similar to that observed in postmenopausal women [9-11], which is concerning as the 
prevalence of CVD is higher in postmenopausal women compared to premenopausal women and 
men [13].  Since endothelial dysfunction is considered to be an essential first step in the 
development of atherosclerosis, short or long-term impairment of endothelial function in 
exercise-trained amenorrheic women might predispose them to further vascular dysfunction, 
detrimental vascular structural changes and ultimately increased cardiovascular risk. However, 
few studies have examined the magnitude of subclinical atherosclerotic CVD (i.e. vascular 
dysfunction beyond the endothelium) in this population. 
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Chapter I: Introduction  
Endothelial dysfunction is proposed as the first step in the atherosclerotic CVD process 
[15]. The endothelium is a single cell layer responsible for the vasodilator capacity of the artery. 
Nitric oxide (NO), a potent vasodilator, is produced by endothelial nitric oxide synthase (eNOS) 
in response to shear stress on the blood vessel wall. Endothelial dysfunction is mainly due to 
reductions in NO bioavailability [14, 15]. It is well known that chronic endothelial dysfunction 
can lead to increased arterial stiffness and vascular remodeling [14, 15]. Increased arterial 
stiffness reduces the vasodilator capacity of the artery and increases blood flow pulsatility [16]. 
Vascular remodeling is a dynamic structural process that occurs due to changes in hemodynamic 
stimuli such as increased pulsatile blood pressure or increased blood flow. Chronic endothelial 
dysfunction and increases in arterial stiffness can aggravate these hemodynamic stimuli and lead 
to vascular damage and further remodeling (i.e. increased lumen diameter and wall thickness) 
[17]. Vascular remodeling is marked by structural arterial changes that may be irreversible, 
ultimately leading to a cardiovascular event (i.e. stroke, myocardial infarction) [22]. Thus, 
interventions that improve endothelial function and arterial stiffness may reduce the progression 
of atherosclerotic CVD and subsequent risk for a cardiovascular event [18, 19].  
Moderate intensity aerobic exercise may reduce the risk for CVD by improving 
endothelial function, arterial stiffness and vascular remodeling (i.e. increased lumen diameter 
and decreased Intima media thickness (IMT)) [5-7, 20-26]. Vascular improvements with exercise 
training are at least partly due to periodic increases in wall shear stress [7, 27-29] and are 
mediated by NO [21, 22, 30-33]. However, the positive effects of aerobic exercise on endothelial 
function and arterial stiffness are intensity dependent. Chronic high intensity exercise can 
actually negatively impact endothelial function and lead to increased arterial stiffness [34-37]. 
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Chronic high-intensity exercise training in women increases risk for the development of The 
Female Athlete Triad. Clinical manifestations of this triad include: low energy availability, 
amenorrhea and osteoporosis [38, 39]. The triad is currently a prevalent medical concern among 
competitive female athletes [38]. In fact, about 65% of long distance runners and dancers will 
develop components of The Female Athlete Triad [40]. The occurrence of the triad is higher 
amongst athletes who participate in sports that require a lower body mass for athletic success, 
such as gymnastics, running and/or dancing [41]. Of the triad components, amenorrhea 
(considered an estrogen deficient state) may have the greatest impact on the development of 
CVD.  
Exercise-trained amenorrheic women might be at premature risk for CVD since 
endothelial dysfunction is observed in these women. Exercise-trained amenorrheic women have 
lower estrogen concentrations, which have been shown to contribute to endothelial dysfunction 
in this population [9-12]. It is currently unknown whether vascular dysfunction in premenopausal 
exercise-trained amenorrheic women extends beyond the endothelium (i.e. increased arterial 
stiffness, increased IMT, increased lumen diameter). Therefore the severity of subclinical 
atherosclerosis in this population is undetermined.  
This study will explore whether there may be more progressive/advanced vascular 
dysfunction in exercise-trained amenorrheic women, beyond endothelial dysfunction, 
manifesting as increases in arterial stiffness and adverse vascular remodeling. Women that 
engage in high intensity exercise (to the point of losing their menstrual cycle) may have 
premature vascular dysfunction (i.e. endothelial dysfunction, increased arterial stiffness and 
adverse vascular remodeling) increasing subclinical atherosclerotic burden and thus future risk 
for CVD.  
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Specific Aims and Expected Outcomes of This Thesis  
Specific Aim 1: To examine endothelial dysfunction in exercise-trained amenorrheic women. 
• Sub-Aim 1: To determine whether endothelial dysfunction is related to lower 
salivary estrogen concentrations in exercise-trained amenorrheics. 
Expected Outcome 1: Exercise-trained amenorrheic women will have lower endothelial function 
compared with exercise-trained eumenorrheic women and similar endothelial function compared 
to sedentary eumenorrheic women. Lower estrogen concentrations in exercise-trained 
amenorrheic women will be associated with lower endothelial function.  
Specific Aim 2: To examine arterial stiffness in exercise-trained amenorrheic women. 
• Sub-Aim 2: To determine whether increased arterial stiffness is related to lower 
salivary estrogen concentrations in exercise-trained amenorrheics. 
Expected Outcome 2: Exercise-trained amenorrheic women will have higher arterial stiffness 
compared with exercise-trained eumenorrheic women and similar arterial stiffness compared to 
sedentary eumenorrheic women. Lower estrogen concentrations in exercise-trained amenorrheic 
women will be associated with higher arterial stiffness. 
Specific Aim 3: To examine vascular remodeling in exercise-trained amenorrheic women. 
• Sub Aim 3: To determine whether vascular remodeling is related to lower salivary 
estrogen concentrations in exercise-trained amenorrheics. 
Expected Outcome 3: Exercise-trained amenorrheic women will have smaller artery diameter 
and larger IMT, compared with exercise-trained eumenorrheics suggesting unfavorable vascular 
remodeling in this cohort. Lower estrogen concentrations in exercise-trained amenorrheic 
women will be associated with larger IMT and smaller superficial femoral diameter (SFA) 
diameter. 
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Chapter II: Literature Review 
The following literature review will introduce the concepts of: 1) endothelial dysfunction, 
arterial stiffness and vascular remodeling; 2) the effect of exercise training on vascular function; 
3) the effect of estrogen on vascular function; and 4) endothelial dysfunction in exercise-trained 
amenorrheic women. This review provides the rationale for a study to examine subclinical 
atherosclerosis in exercise-trained amenorrheics to gain insight into the extent and the severity of 
subclinical atherosclerosis in this population.  
Progression of Subclinical Atherosclerosis  
Cardiovascular disease (CVD) is a leading cause of death among women in the United 
States [1]. Atherosclerotic CVD is a multistage process characterized by structural and functional 
changes to the artery. Initial functional changes to the endothelium result in increased arterial 
stiffness and unfavorable vascular remodeling (Refer to Figure 1). With increasing age and 
reductions in estrogen concentrations after menopause, the risk for CVD becomes higher in 
women than in men [2]. This disparity in risk for CVD may be partly attributable to sex 
differences in arterial function and structure [42-45].  
Endothelial dysfunction is the first detectable event in the atherosclerotic process of CVD 
[46]. Endothelial dysfunction is largely due to reductions in nitric oxide (NO) bioavailability [47, 
48]. NO, a potent vasodilator is produced by the enzyme endothelial nitric oxide synthase 
(eNOS). As blood flows through an artery it comes in contact with the arterial wall or the 
endothelium (inner lining of the blood vessel) and creates shear stress. The dragging force 
stimulates the phosphorylation of eNOS and subsequently, NO production. If left undetected, 
endothelial dysfunction can lead to detrimental structural changes to the vessel wall. The 
stiffness of the artery is influenced both by vascular function (i.e. NO and endothelial function) 
  
6
and vascular structure (i.e. elastin and collagen composition). Increased arterial stiffness 
decreases the ability of the artery to vasodilate and increases blood flow pulsatility [16]. This is 
important because chronic pulsatile blood flow can lead to additional vascular endothelial 
damage [14] and adverse vascular remodeling [15]. Vascular remodeling is an active process that 
occurs due to changes in hemodynamic conditions, such as increased blood pressure and/or 
increased pulsatile blood flow [49, 50]. Remodeling is characterized by changes in arterial lumen 
diameter and clinically relevant changes in wall thickness or intima media thickness (IMT) 
aimed at maintaining a stable hemodynamic environment and vessel wall tension [49, 50]. The 
law of LaPlace defines vessel wall tension as (pressure x radius)/ 2 x wall thickness. Increases in 
hemodynamic forces on the artery wall increase wall tension [49, 50]. Therefore, in order to 
restore wall tension, the artery will remodel. For example, hypertension is associated with 
structural changes manifested as a reduction in lumen diameter and/or increase in IMT [51]. 
These changes maintain optimal wall tension [51]. If undetected, chronic endothelial dysfunction 
and increased arterial stiffness can lead to permanent structural vascular remodeling and 
subsequent cardiovascular events (See Figure 1).  
 
 
 
 
Aerobic Exercise Training and Subclinical Atherosclerosis 
Aerobic exercise improves endothelial function [52] as exercise transiently increases 
blood flow, shear stress and ultimately NO bioavailability [6, 22-25, 28-33, 53-56]. Indeed the 
Adverse 
Vascular 
Remodeling 
Endothelial  
Dysfunction 
Increased  
Arterial 
Stiffness 
Figure 1: Chronic endothelial dysfunction can lead to 
increased arterial stiffness, adverse vascular remodeling and 
ultimately, risk for a cardiovascular event. 
Cardiovascular  
Event  
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shear stress stimulus is necessary for favorable vascular improvements seen with exercise on the 
endothelium; experimental abolishment of shear with exercise prevents improvements in 
endothelial function [20, 21, 27]. In addition to endothelial function, aerobic exercise can lead to 
improvements/reductions in arterial stiffness [37, 57-61]. Aerobic exercise improves arterial 
stiffness irrespective of training modality (i.e. walking, swimming, running, cycling) [70, 72, 
73]. Interestingly, the benefits of exercise on arterial stiffness might be mediated by NO release. 
It has been shown that after long-term exercise training, plasma NO concentrations are inversely 
associated with arterial stiffness [62]. Similarly, animal studies support a NO mediated 
mechanism for improvements in arterial stiffness with aerobic exercise. In a study examining 
arterial stiffness in rats, aortic stiffness was lower in exercise-trained rats compared to sedentary 
rats [63]. A microarray DNA technique determined that aerobic exercise training up-regulated 
eNOS, and subsequently NO production and this was associated with favorable changes in 
arterial stiffness [63]. These findings suggest that long term exercise training leads to increased 
NO release and subsequent improvements in central arterial stiffness [57].  
In addition to improvements in endothelial function and arterial stiffness, exercise 
training is believed to lead to favorable vascular remodeling marked by a larger lumen diameter 
and smaller IMT. Physical activity levels are inversely associated with IMT, and positively 
associated with lumen diameter [49, 50, 64-66]. Exercise-trained individuals have substantial 
arterial structural remodeling [49, 67, 68] as a result of localized or systemic vascular stimuli. In 
a cross-sectional study it was reported that predominantly lower-limb exercise training leads to a 
larger diameter of the SFA, while predominantly upper-limb exercise training leads to a larger 
diameter of the brachial artery [65]. In exercise-trained individuals, the IMT is systematically 
smaller compared to sedentary individuals [64]. Regular aerobic/endurance exercise results in 
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regularly sustained elevations in blood flow [34]. Increases in blood flow increase shear stress 
and vascular NO release, which have been shown to contribute to reductions in IMT and 
increases in arterial diameters [34]. Vascular remodeling stemming from exercise training might 
be NO mediated and occur to maintain appropriate levels of shear stress and minimize wall strain 
that accompanies exercise training [61].  
However, the positive effects of aerobic exercise on endothelial function, arterial stiffness 
and vascular remodeling might be intensity dependent. Previous studies have found that 
endothelial dysfunction occurs following long distance, repetitive, high intensity exercise 
sessions such as running a marathon [35, 36, 69]. Also, resting arterial stiffness is elevated in 
marathon and ultra-marathon runners compared to their sedentary counterparts [61]. Similar 
mechanisms are proposed for endothelial dysfunction and increased arterial stiffness due to high 
intensity exercise training: both excessively high shear stress and high levels of oxidative stress 
that occur with chronic high intensity exercise training reduces NO bioavailability [69-72]. This 
is supported by previous studies noting similar IMT between exercise-trained individuals and 
their sedentary counterparts [73, 74]. This suggests that chronic high intensity exercise leads not 
only to endothelial dysfunction and increased stiffness but might also lead to adverse vascular 
remodeling.  
Exercise-Associated Amenorrhea and Vascular Function  
In women, chronic high intensity exercise, when combined with energy deficiency, can 
lead to exercise-associated amenorrhea. Due to a hypoestrogenic state, exercise-trained 
amenorrheic women lack a menstrual cycle as occurs in post-menopausal women. As such, it has 
been demonstrated that exercise-trained amenorrheic women have comparable levels of vascular 
dysfunction to that witnessed in post-menopausal women [9-11, 71]. Recent studies show that 
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exercise-trained amenorrheic women have lower endothelial function compared with exercise-
trained eumenorrheics (i.e. regular menstruating women) [9-11, 71]. In these studies, endothelial 
dysfunction observed in exercise-trained amenorrheic women was directly associated with lower 
levels of serum estrogen (See Figure 2) [10, 29, 71, 75].  
Amenorrhea, Estrogen and Vascular Function   
Estrogen receptors are located on the endothelium and stimulate the production of eNOS, 
leading to increased production of NO that causes vasodilation [76]. Endothelial function 
fluctuates across the menstrual cycle in conjunction with estrogen concentrations [76, 77]. 
Recent studies examined endothelial function at 4 time points in the menstrual cycle: early 
follicular, late follicular, early luteal and late luteal [72, 73]. Endothelial function, NO and 
estrogen concentrations are all highest in the late follicular phase, and lowest in the early 
follicular phase [77, 78]. Arterial stiffness does not fluctuate as strongly across the menstrual 
cycle, however, estrogen concentrations do impact arterial stiffness [77-80]. Decreases in 
estrogen concentrations, such as occurs in post-menopausal women, increases arterial stiffness 
[81]. In animal studies, estrogen therapy significantly increased NO bioavailability [82]. 
Similarly, estrogen infusion transiently reduces arterial stiffness in postmenopausal women [83].  
There is also evidence to suggest that low estrogen in postmenopausal women may 
contribute to larger IMT, a measurement of adverse structural arterial remodeling [78-80]. 
Supplemental estrogen via hormone replacement therapy, in postmenopausal women, reduces 
IMT [83-85]. Specifically, estrogen therapy and selective estrogen receptor modulators 
significantly reduce femoral IMT [86] and carotid IMT [87] in postmenopausal women, leading 
to values closer to young premenopausal women. Estrogen may regulate NO by increasing the 
production of eNOS and the release of NO [76], further improving vascular remodeling. While 
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estrogen deficiencies and estrogen therapy have been shown to affect indices of remodeling via 
the IMT, their effect on arterial diameter is largely unknown [88].  
Ultimately, female sex hormones may help to explain the disparity in CVD risk between 
men and women, especially since these differences seem to be only present during reproductive 
years [89]. Thus, estrogen deficiency may lead to premature endothelial dysfunction, increased 
arterial stiffness and adverse vascular remodeling (See Figure 2) [90]. 
 
 
 
 
 
 
Diet and Vascular Function  
In addition to exercise and disease states, dietary intake has an effect on vascular 
function. Exercise-trained women are more susceptible to inadequate dietary intake or energy 
deficiency compared to their male counterparts [91]. The female athlete triad not only includes 
amenorrhea but also includes disordered eating which can lead to low energy availability and 
may also contribute to the development of amenorrhea [10]. It is suggested that in addition to the 
contribution of low estrogen concentrations to vascular dysfunction in exercise-trained 
amenorrheic women, disordered eating and subsequent energy deficiency may also mediate 
vascular dysfunction observed in exercise-trained amenorrheic women [38]. Some of the 
Endothelial  
Dysfunction 
Increased  
Arterial 
Stiffness 
Adverse 
Vascular 
Remodeling 
Amenorrhea 
Low Estrogen 
Figure 2: Hypoestrogenism observed in exercise-trained amenorrheic women 
might contribute to endothelial dysfunction, increased arterial stiffness, adverse 
vascular remodeling and ultimately, risk for a cardiovascular event. 
Cardiovascular 
Event 
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vascular dysfunction observed in exercise-trained or sedentary women may be due to the lack of 
or over-consumption of specific nutrients, minerals and vitamins [86]. Therefore, dietary intake 
is an influential variable to consider when evaluating vascular function in exercise-trained 
individuals.  
Exercise-trained females are commonly deficient in their dietary fat intake [92]. Although 
a high fat diet can lead to endothelial dysfunction, increases in arterial stiffness, [93, 94] and a 
larger IMT [95], deficiencies in dietary fat in female athletes may give greater insight into the 
causes of menstrual irregularities such as amenorrhea. Normal dietary fat intake has been 
reported to be necessary to maintain concentrations of sex hormones and may prevent menstrual 
disturbances in female athletes [91, 96].  
Other common nutrient deficiencies in exercise-trained females that may affect 
endothelial function and arterial stiffness are, antioxidants, B-vitamins, zinc and iron [92].  
Antioxidants have a favorable effect on endothelial function and arterial stiffness, as they 
provide vascular defense against oxidative stress [97]. B-vitamins have antioxidant-like 
properties and reduce arterial stiffness by inhibiting the breakdown of NO by free radicals [94].  
Therefore, antioxidants and B-vitamin deficiencies in female athletes may lead to endothelial 
dysfunction and increased arterial stiffness. Likewise, zinc deficiencies have been linked to 
increased blood pressure and impaired NO activity [98] affecting endothelial function and 
arterial stiffness. Lastly, iron intake can contribute to endothelial dysfunction [99] and arterial 
stiffness [100]. While maintenance of necessary iron stores is essential for the female athlete, 
excessive iron stores are linked to increases in oxidative stress and therefore endothelial 
dysfunction [93]. Iron deficiencies, such as anemia, commonly observed in female athletes, have 
been shown to affect NO production and therefore, endothelial function [101]. Considering the 
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effects of specific nutrient intakes and deficiencies on vascular function, dietary intake is an 
essential component when examining vascular function in exercise-trained women.  
Rationale for the Current Study 
Exercise-trained amenorrheic women have endothelial dysfunction. It is currently 
unknown whether these women have higher arterial stiffness and adverse vascular remodeling; 
more advanced stages of subclinical atherosclerosis (See Figure 3, Dashed arrows/boxes 
represent what is unknown, solid arrows/boxes represent what is known). There is a strong 
relationship between estrogen, endothelial dysfunction and increased arterial stiffness. Estrogen 
has a favorable effect on vascular structure and function. Considering the association between 
estrogen, endothelial function and arterial stiffness, it seems plausible to hypothesize that chronic 
estrogen deficiency/endothelial dysfunction will lead to increased arterial stiffening and 
maladaptive vascular remodeling. This study examined endothelial dysfunction, arterial stiffness 
and vascular remodeling in highly exercise-trained women to gain insight into the effect of 
exercise-associated amenorrhea on subclinical atherosclerosis and risk for CVD in this cohort.  
 
 
 
 
 
 
 
 
 
Endothelial  
Dysfunction 
Amenorrhea 
Low Estrogen 
Increased  
Arterial Stiffness 
Adverse 
Vascular 
Remodeling 
Cardiovascular 
Event 
Figure 3: It is currently unknown whether exercise-trained amenorrheic women have 
increased arterial stiffness (dashed arrow/box) and adverse vascular remodeling (dashed 
arrow/box). Thus, premature CVD needs to be examined in this population. 
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Chapter III: Methods 
Participants:  Forty-three women participated in this cross-sectional study: 10 exercise-trained 
amenorrheic women, 18 exercise-trained eumenorrheic women, and 15 sedentary/recreationally 
active eumenorrheic women. Participants were between the ages of 18-30 years, to avoid the 
influence of age-related vascular dysfunction that has been shown to occur beyond 30-35 years 
of age. Participants were recruited from Syracuse University, university collegiate sports teams, 
local colleges (Upstate Medical University, LeMoyne College) and athletic clubs (Syracuse 
Chargers, Fleet Feet Sports, Central New York Triathlon Team) in the Central New York Area. 
Recruitment was via flyers, word of mouth, emails and advertisements. Written informed 
consent was obtained from all participants. The Syracuse University Institutional Review Board 
approved this study.  
Inclusion Criteria: Healthy exercise-trained and sedentary/recreationally active female 
participants with and without amenorrhea were included in this study. Participants were stratified 
into physical activity groups according to self-report via the Paffenbarger Physical Activity 
Questionnaire (Appendix 2). From this validated questionnaire [102], a Physical Activity Index 
(PAI) was determined from Intensity, Duration, and Frequency of activity (maximal score is 
100). A maximal aerobic capacity test was administered to confirm the participants’ fitness 
grouping determined from questionnaire. The amenorrheic group consisted of both primary 
amenorrhea (absence of menses by age 15) and secondary amenorrhea (absence of 3 consecutive 
menstrual cycles after menarche).  The eumenorrheic group consisted of women with menstrual 
bleeding every 26 to 32 days for at least 12 months. Menstrual status was determined via a 
Health History Questionnaire (Appendix 4).  
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Exclusion Criteria: Participants were excluded from the study if they were pregnant (determined 
using a urine pregnancy test), hypertensive (systolic blood pressure greater than or equal to 140 
mmHg; diastolic blood pressure greater than or equal to 90 mmHg), cigarette smokers, had a 
history of thyroid disorders, diabetes mellitus, or CVD (stroke, heart attack or any past cardiac 
events), as determined by a health history questionnaire.  
Study Design: This was a cross-sectional study examining vascular function across fitness levels 
and menstrual status. Subjects visited the Human Performance Laboratory on one occasion. 
Subjects with eumenorrhea completed the study visit during the early follicular stage (within 1-7 
days following the start of the menses) of their menstrual cycle. Amenorrheic subjects completed 
the study visit at any time, unless they were currently taking oral contraceptives, in which case 
they were asked to come in during the placebo phase of the contraceptive pill. This was done to 
control for the potential hormonal effects of oral contraceptives on vascular function.   
Measures were performed first thing in the morning with the participant in a fasted state 
(>12 hours post-prandial, no caffeine, no alcohol). Participants were also asked to consume 16 
ounces of water the night before their visit and the morning of the testing to moderately control 
for hydration. Prior to arriving at the laboratory, subjects were asked to complete a 3-day dietary 
record (two weekdays, one weekend day) to ensure that the dietary intake was not the underlying 
reason for potential vascular dysfunction and to examine dietary patterns in exercise-trained 
amenorrheic women. Subjects signed the informed consent form, filled out the questionnaires: 
health history, physical activity, and the female athlete triad questionnaire. Participants were 
required to lie in the supine position on the exam table for at least ten minutes in a dimly lit 
climate controlled room before all hemodynamic measures. At this time, flow-mediated dilation 
(FMD), pulse wave velocity (PWV), and vascular ultrasonography were performed as measures 
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of endothelial function, arterial stiffness and remodeling, respectively. Following vascular 
measurements, blood lipids, hemoglobin, hematocrit and saliva collection for estrogen analysis 
were performed. Lastly, body fat, using air displacement plethysmography (Bod Pod) was 
measured and then cardiorespiratory fitness assessed by the maximal oxygen uptake during an 
exercise test (VO2 max test) was measured. All consent and testing procedures took 
approximately 90 minutes.  
Blood Pressure: Systolic (SBP) and diastolic (DBP) brachial blood pressure was measured prior 
to vascular measurements via a validated automated oscillometric cuff (EW3109, Panasonic 
Electric Works, Secaucus NJ).  Pressures were taken in duplicate and averaged. If values were 
different by more than 5 mmHg a third measure was obtained.  Pulse Pressure (PP) was 
calculated as DBP subtracted from SBP.  
Endothelial-dependent Flow Mediated Dilation (FMD): A non-invasive method of assessing 
endothelial dysfunction is FMD, calculated as the percentage change in arterial diameter due to 
blood ischemia and reactive hyperemia. The FMD protocol induces reactive hyperemia, which 
occurs after blood flow to a conduit vessel is occluded. After the release of the occlusion, blood 
flow is increased compared to baseline flow. This results in increases in shear stress, which leads 
to release of NO and subsequent vasodilation. A larger change in diameter indicates healthier 
endothelial function while a smaller change in diameter indicates abnormal endothelial function 
or endothelial dysfunction. In a recent study, FMD predicted cardiac events in 2000 subjects and 
a significant inverse relationship between cardiovascular events and FMD exists for the 
prognosis of atherosclerosis [19].  
In the current study, endothelium-dependent vasodilation of the brachial artery was 
assessed using ultrasound (Prosound α7, Aloka, Tokyo, Japan). The brachial artery was 
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longitudinally imaged 2-cm distal to the antecubital fossa using a 5.0-13.0 MHz linear array 
probe. Baseline diameters were measured during end-diastole (measured by ECG R-waves) and 
end-systole (measured by the end of the ECG T-wave) using ultrasonic calipers. Average 
brachial diameter was calculated as 1/3systolic diameter + 2/3diastolic diameter. Following 
baseline brachial artery diameter measurements, a blood pressure cuff was placed around the 
lower arm and inflated to a supra-systolic pressure (200 mmHg) for 5 minutes (Hokanson, 
Bellevue, WA). Following this occlusion period, the cuff was released causing reactive 
hyperemia. Maximum velocity (Vm) was measured continuously for 25-30 seconds following 
cuff release (time 0 – 30s post cuff release). Following this initial 30s post cuff release 
measurement, brachial diameters were continuously measured for an additional 2-minutes (time 
30s – 150s post cuff release). FMD was expressed as a percentage and calculated as: the baseline 
diastolic diameter (determined from ECG gating) subtracted from the peak diastolic diameter, 
divided by the baseline diastolic diameter and taken as a measure of endothelial function. Beat-
to-beat mean velocity (MnV) noted during the 25-30 seconds post occlusion were entered into a 
software program (Graphpad, Prism, 3.0) to calculate the area under the curve (AUC) of the 
reactive hyperemic response to cuff deflation as an estimate of the shear stress stimulus [103]. 
The peak Vm within the first 30s immediately following cuff deflation was also recorded as a 
measure of microvascular reactivity [104].  
Pulse Wave Velocity (PWV): A pressure wave is created when the left ventricle contracts and 
then travels throughout the vascular system. PWV is the rate at which the pressure wave travels 
through the arterial tree (the higher the PWV, the stiffer the arteries). Arterial stiffness is directly 
related to risk for cardiovascular events [17, 105, 106] A recent study reported that increased 
PWV is significantly associated with the first stroke and when assessed in conjunction with other 
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risk factors (such as, age, cholesterol. Diabetes, smoking, blood pressure), central PWV 
improved risk prediction for CVD [16]. Similarly, PWV assessed in a hypertensive population 
positively correlated with future stroke death [107].  
In the current study, blood pressure waveforms were measured in the carotid, radial, 
ankle (posterior tibial) and femoral arteries using applanation tonometry (AtCor Medical, 
SpygmoCor Technology). Aortic stiffness was measured using carotid-femoral PWV. The 
distance between the super-sternal notch and the carotid pulse-site was measured and the 
distance between the super-sternal notch and the femoral pulse-site was measured. These 
distances were subtracted to determine the distance between the carotid and femoral pulse sites. 
Peripheral stiffness was measured using carotid-radial PWV and femoral-ankle PWV. The 
distance between the super-sternal notch and the carotid was measured and next the distance 
between the super-sternal notch and the radial pulse-site were measured. These distances were 
subtracted to determine the distance between the carotid and radial pulse sites. Lastly, the 
distance between the super-sternal notch and the femoral were measured and the distance 
between the super-sternal notch and the posterior-tibial were measured. These distances were 
subtracted to determine the distance between the femoral and ankle pulse sites. The equation 
used to determine PWV is: ∆ distance (m) / ∆ time (s).  
Superficial Femoral Artery (SFA) Structure One indication of vascular remodeling is an 
increase in the intima media wall thickness (IMT). Increased IMT, both centrally and 
peripherally, is linked with future cardiovascular events [108, 109]. Increases in IMT are due to a 
combination of intimal hyperplasia/diffusive atherosclerosis and medial smooth muscle 
hypertrophy in response to increased pulsatility [110, 111]. An increase in femoral (peripheral) 
IMT is a marker of atherosclerosis and vascular remodeling [68, 108, 112]. In the current study 
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we assessed vascular remodeling by examining the IMT and lumen diameter of the superficial 
femoral artery (SFA). The SFA was imaged using Doppler ultrasound (ProSound α7, Aloka, 
Tokyo, Japan) attached to a 5.0-13.0 MHz linear-array probe. The artery was imaged 
approximately 8-10 cm distal to the bifurcation of the common femoral artery (CFA). SFA 
diameters during diastole (R wave) and during systole (T wave) were recorded using ultrasonic 
calipers. SFA intima-media thickness (IMT) was assessed as the distance from the near wall to 
far wall lumen-intima interface using a longitudinal view of the artery with both near wall and 
far wall lumen-IMT boundaries clearly visible. The average SFA diameter was evaluated as 
1/3systolic diameter + 2/3diastolic diameter. Both measures of IMT and SFA diameter were used 
as indices of vascular remodeling.  
Biochemical Analyses of 17Beta-Estradiol: 17-Beta estradiol was measured to verify the 
hormonal status of the women participants. Estradiol was detected in whole saliva samples, using 
a highly sensitive competitive binding immunoassay (Salimetrics State College, PA). In this 
particular immunoassay the bound estradiol peroxidase was detected using a spectrophotometer 
at 450 nm (with a correction of 630nm). The estradiol peroxidase was inversely proportional to 
the amount of free estradiol present in the saliva samples such that the higher optical density 
(OD) in the plate represented lower estradiol concentrations, while the lower OD in the plates 
represented higher estradiol concentrations. All samples were collected in the morning during the 
early follicular phase of the menstrual cycle. 
Aerobic Capacity: A graded exercise test using a treadmill (T150 Med) was used to assess each 
participant’s maximal aerobic capacity. Speed and grade were increased until participants 
reached volitional fatigue. The highly trained endurance participants started the test at a speed of 
3.5 mph, and every two minutes the speed was increased until a speed of 8.5 mph was achieved. 
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After this stage, the grade was increased by 2.5% every two minutes until the participant reached 
exhaustion. For the recreationally active/sedentary individuals, the speed started at 3.5 mph and 
was increased every two minutes until a speed of 7.5 mph was achieved, at which point grade 
was increased by 2.5% every two minutes until exhaustion was achieved. Heart rate and Rated 
Perceived Exertion (RPE) were assessed during the stages using a Polar Heart Rate Monitor and 
an RPE chart, respectively. A metabolic cart was used for breath-by-breath gas analysis of 
oxygen and carbon dioxide (Parvo Medics). The calibration procedure included the flow meter 
(using a 3L syringe to mimic normal lung volume) calibration and gas calibration in which the 
ideal values were between .01-.03%. Peak aerobic capacity was taken as the highest VO2 
obtained. A test was considered valid if: an R-value of 1.15 and a RPE greater than 17 was 
achieved. 
Menstrual Status: A self-administered health history questionnaire was administered to 
determine the age of menarche (i.e. the age of onset of first menses), gynecological age (i.e. the 
difference between chronological age and age at menarche), number of menstrual cycles per 
year, number of days between menses, skipped menses, and use and type of birth control. For the 
purpose of this study the eumenorrheic women were defined as menstrual bleeding every 26 to 
32 days for at least 12 months. Primary amenorrhea was defined as the absence of menarche by 
the age of 15 and secondary amenorrhea as the cessation of menses for greater than three 
consecutive cycles after onset of menarche [38].  
Body Composition: Participants’ body composition was assessed using air displacement 
phlethysmography (BodPod; COSMED, Concord, CA), to estimate lean body mass and fat mass. 
Participants’ height (cm) and weight (kg) were measured using a wall stadiometer and scale, 
respectively. Participants were instructed to wear minimal tight fitting clothing (i.e. compression 
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shorts, a sports bra or a swimsuit, and swim cap). They were asked to sit quietly in the pressure 
chamber while the total body volume was measured. 
3-Day Dietary Record: Participants were instructed to record their dietary intake for two 
weekdays and one weekend prior to the testing session. The dietary recall was analyzed for 
percentage of carbohydrate, protein, and fat, kilo-calorie content, and other nutrients, minerals, 
viatmins using a freely available software (supertracker.usda.gov, My Plate Software).  
Blood Lipids: Total cholesterol, High Density Lipoprotein (HDL), Low Density Lipoprotein 
(LDL), triglycerides (TG) and glucose (GLU) levels were measured (Cholestech LDX, Alere). 
Briefly, a finger lancet was used to obtain a droplet of blood from the index finger of the non-
dominant hand. The droplet was transferred to a cartridge to be loaded and read by the automated 
Cholestech device. This technique has previously been established to be valid and reliable (mean 
r = .97 for total cholesterol, HDL, LDL, TG, GLU, Alere, Medical). 
Hematocrit: The proportion by volume of red blood cells or hematocrit was analyzed using a 
finger lancet to obtain a droplet of blood from the index finger of the non-dominant hand, which 
was centrifuged into plasma and red blood cells using CritSpin Micro-hematocrit centrifuge 
(StatSpin, Inc, Norwood, Mass).  
Hemoglobin: Hemoglobin was analyzed using a finger lancet to obtain a droplet of blood from 
the index finger of the non-dominant hand. With a disposable microcuvette, this droplet was  
transferred, similar to the blood lipid measurement, to a blood analyzer  (The Hemocue 
Hemoglobin System, Hb201+; Angelholm, Sweden). 
Statistical Analyses: All variables were tested for non-normality using Shapiro-Wilk test and 
Kolmogorov-Smirnov test for normality, before statistical hypothesis tests were performed. Data 
for continuous variables were analyzed using a one-way ANOVA. Categorical variables from the 
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Female Athlete Triad Questionnaire were analyzed using chi-square goodness of fit tests. When 
a significant main effect was detected between groups a Tukey Post Hoc Analysis was 
performed. Analysis of covariance (ANCOVA) was performed to adjust for the AUC (shear 
stress stimulus) for FMD responses. Pearson’s bivariate correlations were performed between 
estrogen, body fat, VO2 max and the following variables: FMD, PWV, IMT and SFA diameter. 
A significance level was set at P ≤ 0.05. All data was presented as means ± standard deviation. 
Statistical Package for the Social Sciences (SPSS 20.0) was used for data analysis. 
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Chapter IV: Results 
Participant Characteristics. Participant descriptive characteristics are shown in Table 1. 
Participants were well matched across groups for age, height, and weight (Table 1; p<0.05).  
Body fat percentage (%) was significantly different between groups (p<0.05). Body fat 
percentage was significantly lower in the exercise-trained amenorrheic group compared with 
both eumenorrheic groups (p<0.05), while the exercise-trained eumenorrheic group had 
significantly lower body fat percentage compared with the sedentary eumenorrheic group 
(p<0.05; Table 1). The physical activity index (PAI), calculated from the Paffenbarger Physical 
Activity Questionnaire was significantly different between groups; specifically the exercise 
trained eumenorrheic and amenorrheic group had a significantly higher PAI than the sedentary 
group (p<0.05). The exercise-trained amenorrheics had a significantly higher VO2 Max 
(ml/kg/min) than the exercise-trained eumenorrheics and the sedentary group (p<0.05; Table 1). 
According to The World Health Organization (WHO, 1997) the gender and age specific 
guidelines for anemia in women are a hemoglobin value below 12 g/dl and a hematocrit below 
36%. Ten women fell below the criteria for hemoglobin and hematocrit and thus, had mild to 
moderate anemia at the time of the study. Six women had hematocrit values of less than 36% (3 
exercise-trained amenorrheic women, 1 exercise-trained eumenorrheic woman, 2 sedentary 
eumenorrheic women), and 5 women had hemoglobin values less than 12 g/dl (1 exercise-trained 
amenorrheic woman, 1 exercise-trained eumenorrheic woman, 3 sedentary eumenorrheic 
women). 
Area Under the Curve (AUC) and Peak Velocity.  AUC calculated from the recorded blood 
velocities 25-30 seconds post release of blood pressure cuff occlusion during the FMD protocol, 
is presented in Table 3. A significant main effect for AUC was detected between groups 
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(p<0.05). Post hoc analyses denoted that the exercise-trained amenorrheic group had a 
significantly lower AUC compared to the sedentary group (p<0.05). In contrast, the peak 
velocity during the reactive hyperemic response was not significantly different between the three 
groups (p>0.05).  
Endothelial-dependent Flow Mediated Dilation (FMD). FMD of the brachial artery data are 
presented in Table 3. No significant main effect was detected for FMD between groups (p=0.07). 
An analysis of covariance (ANCOVA) was performed between FMD to properly adjust for AUC 
(a measure of the shear stress stimulus), as is customary with this measure [113]. When FMD 
was adjusted for AUC, the exercise-trained amenorrheics had significantly lower FMD compared 
to the exercise trained and sedentary eumenorrheics (p<0.05; Figure 1).  
Pulse-Wave Velocity (PWV). In this cross sectional design, PWV was measured at the carotid-
femoral, carotid-radial, and the carotid-ankle pulse sites and is presented in Table 3. Carotid 
femoral PWV was significantly different between groups. Post-hoc analyses indicated that 
carotid-femoral PWV was significantly higher in the sedentary group compared to the exercise-
trained eumenorrheic group (p<0.05) but not significantly different from the exercise-trained 
amenorrheic group (p> 0.05; Figure 2). No significant differences were found in carotid-radial 
and femoral-ankle PWV (p>0.05).  
Superficial Femoral Artery (SFA) Structure. Resting SFA diameters and IMT are presented in 
Table 4. For SFA diastolic diameter and SFA IMT, a significant main effect was detected 
(p<0.05; Figure 3, and Figure 4, respectively). Post hoc analyses determined that the exercise-
trained amenorrheics and eumenorrheics had a significantly higher SFA diastolic diameter when 
compared to the sedentary eumenorrheics (p<0.05). However, the exercise-trained amenorrheic 
women had significantly smaller IMT compared to the sedentary group (p<0.05).  
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Menstrual Status and Biochemical Analyses of 17B-estradiol. Menstrual history/characteristics 
are presented in Table 2. Age at menarche was significantly different, with the exercise-trained 
amenorrheics having a significantly higher age of menarche compared to exercise-trained and 
sedentary eumenorrheics (p < 0.05). Likewise, gynecological age was significantly lower in the 
amenorrheic group compared to the sedentary group (p <0.05). In the sedentary group one 
estradiol concentration had to be excluded due to measurement error (n = 14 from n = 15). 17B-
estradiol was not significantly different between groups (p > 0.05). 55.8% of the women were on 
oral contraceptives (50% of exercise-trained amenorrheic women, 61% of exercise-trained 
eumenorrheic women, 60% of sedentary eumenorrheic women) and the proportion did not differ 
across groups (p>0.05). According to the female athlete triad questionnaire, the average number 
of responses, on an 8 point scale on body composition issues across groups was not significantly 
different (Average of 2.3 responses for exercise-trained amenorrheic women, 3.0 for exercise-
trained eumenorrheic women, 2.07 for sedentary eumenorrheic women, p>0.05). Also the 
proportion of women across the three groups that reported a previous stress fracture was not 
significantly different, 20% of exercise-trained amenorrheic women, 33.3% of exercise-trained 
eumenorrheic women, 26.7% or sedentary eumenorrheic women (p>0.05).  
3-Day Dietary Record Characteristics. Based on a three-day dietary record (two weekdays and 
two weekends), means of dietary information, nutrients, minerals, vitamins are presented in 
Table 5. Nutrients. A significant difference in the protein consumption was detected between 
groups, in which the exercise-trained amenorrheic women consumed significantly more protein 
than sedentary eumenorrheic group (p<0.05; Table 5). All other nutrients presented in Table 5 
were not significantly different when compared across groups (p>0.05). Minerals. Significant 
differences were found in potassium, magnesium, phosphorous, and zinc levels (p<0.05; Table 
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5). Post hoc tests revealed that the exercise-trained amenorrheic group consumed a significantly 
higher level of these minerals than the sedentary group (p<0.05). Vitamins. Significant 
differences were found in vitamin B6, Riboflavin, Niacin, and Choline (p<0.05; Table 5). 
Specifically, the exercise-trained amenorrheics consumed significantly more Vitamin B6, and 
Choline than the sedentary group, and consumed significantly more riboflavin and niacin than 
both sedentary and exercise-trained eumenorrheic groups (p<0.05).  
Correlations: 
Pearson’s bivariate correlations between estrogen and FMD, PWV, SFA IMT, SFA diameter, 
values were performed to determine associations between vascular dysfunction and estrogen 
concentrations. No significant correlation was found between estrogen and any vascular 
parameters assessed (Table 6, p>0.05).  
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Chapter V: Discussion  
Using a cross-sectional study design we examined subclinical atherosclerotic 
cardiovascular disease (CVD) risk in exercise-trained amenorrheic women. Endothelial function 
was significantly lower in exercise-trained amenorrheic women compared with both exercise-
trained eumenorrheic and sedentary eumenorrheic women. However, arterial stiffness in 
exercise-trained amenorrheic women was not different from their eumenorrheic counterparts, 
irrespective of training status. Also, exercise-trained amenorrheic women had similar favorable 
vascular remodeling compared to exercise-trained eumenorrheic women (i.e. larger SFA 
diameter and smaller IMT compared to sedentary eumenorrheic women). The main findings of 
this study indicate that exercise-trained amenorrheic women have endothelial dysfunction but 
may not have increased arterial stiffness and negative vascular remodeling. Thus, vascular 
dysfunction in exercise-trained amenorrheic women may not extend beyond the endothelium. 
Moderate intensity exercise improves vascular function, which has been suggested to 
reduce risk for CVD [5, 24-27, 30-36, 46-48] but chronic high intensity exercise can lead to 
vascular dysfunction [54, 67]. In women low energy availability combined with chronic high 
intensity exercise may lead to exercise-associated amenorrhea. The amenorrheic state has been 
associated with endothelial dysfunction [9-11, 71, 114]. In support of previous literature we 
found that exercise-trained amenorrheic women had significant endothelial dysfunction 
compared to their eumenorrheic counterparts.  
It has been suggested that chronic endothelial dysfunction may lead to progressive 
structural changes to the vessel wall such as increases in arterial stiffness [16]. This is important 
because increased arterial stiffness is associated with increased risk for CVD and future 
cardiovascular events [3, 18]. However, we found that arterial stiffness in amenorrheic women 
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was similar to eumenorrheic women, irrespective of training status. Our finding is novel in that 
no previous studies have examined arterial stiffness in exercise-trained amenorrheic women. 
Previous studies have reported increased arterial stiffness in athletes that engage in high intensity 
aerobic/endurance exercise training (i.e. marathon runners) [61] but this finding is not universal 
[57]. Our study expands these findings to suggest that chronic high intensity exercise may not 
increase arterial stiffness in amenorrheic women.  
In general, exercise training leads to favorable vascular remodeling marked by larger 
arterial diameters and smaller IMT, which helps to increase blood flow to the active skeletal 
muscle while maintaining appropriate vessel wall tension and shear stress [49, 50, 115]. Previous 
cross sectional studies have found larger conduit artery diameters and smaller IMT in exercise-
trained individuals [116-118]. It was hypothesized herein that chronic detrimental, functional 
changes to the endothelium might ultimately lead to unfavorable vascular remodeling [22]. We 
found that the exercise-trained amenorrheic and eumenorrheic women both had significantly 
larger SFA diameters and the amenorrheic group significantly smaller IMT than the sedentary 
women. This present study is novel in its examination of vascular remodeling of the SFA in 
exercise-trained amenorrheic women and suggests that amenorrhea does not negatively affect 
favorable vascular remodeling in response to chronic aerobic/endurance exercise training.  
 Similar to postmenopausal women, exercise-trained amenorrheic women lack a 
menstrual cycle and have lower levels of estrogen compared to premenopausal eumenorrheic 
women. As previously discussed, estrogen plays an important role in vascular function, 
particularly in the activation of eNOS and the production of NO [119]. Hypoestrogenism 
contributes to endothelial dysfunction [120-122], and increased arterial stiffness [77-78]. 
Estrogen therapy is also shown to decrease IMT in postmenopausal women [79-81]. Lower 
  
28
estrogen concentrations have been linked to endothelial dysfunction in young premenopausal 
exercise-trained amenorrheic women [9, 11]. Contrary to our hypothesis, we did not find 
differences between the groups of women in salivary estrogen concentrations. Moreover, there 
were no associations between vascular parameters and estrogen concentrations.  
A potential explanation for similarities in estrogen concentrations between groups might 
be due to the time of estrogen measurement in the current study. By study design, we measured 
salivary estrogen concentrations at one time point during the early follicular phase of the 
eumenorrheic menstrual cycle (i.e. 1-7 days after the onset of the menses phase). During this 
phase estrogen concentrations and FMD responses have been found to be at their lowest [72, 73]. 
However, we still hypothesized that there would be differences in estrogen concentrations. It is 
interesting to note that even at the time point in the eumenorrheic menstrual cycle when FMD 
and estrogen concentrations are at their lowest, exercise-trained amenorrheic women still had 
significantly lower FMD (i.e. endothelial function) compared to eumenorrheic women, 
irrespective of training status [114]. This points to a chronic hypoestrogenic effect rather than an 
acute response to decreases in estrogen.  
An alternative mechanism for endothelial dysfunction in the exercise-trained amenorrheic 
women might be oxidative stress. Aerobic exercise is beneficial to vascular health but chronic 
high intensity exercise can lead to increased oxidative stress [72]. It is well known that increased 
free radical concentrations, which accompany oxidative stress, decrease NO bioavailability, the 
primary cause for endothelial dysfunction [14, 123]. This could theoretically affect endothelial 
function without affecting arterial stiffness. Therefore, future studies should examine levels of 
oxidative stress as a potential mechanism of endothelial dysfunction in exercise-trained 
amenorrheic women.  
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Lastly, the female athlete triad not only incorporates amenorrhea but also includes low 
energy availability [7]. In addition to low estrogen concentrations, low energy availability may 
contribute to vascular dysfunction in exercise-trained amenorrheic women. Several nutrients 
deficiencies in exercise-trained women are established to influence vascular function [87]. After 
examination of the dietary patterns of our participants’ nutrient intake was significantly higher in 
the exercise-trained amenorrheics as compared to the eumenorrheic women. This study suggests 
that endothelial dysfunction may not be due to nutrient deficiencies in exercise-trained 
amenorrheic women.  
Limitations 
  Despite our novel findings there are limitations to the current study. The cross sectional 
nature of the study design does not allow us to adequately explore the mechanism for endothelial 
dysfunction in exercise-trained amenorrheic women or explain casual relationships. Thus, a 
longitudinal study design might provide insight into cyclic hormonal fluctuations, chronic 
estrogen load and endothelial dysfunction in exercise-trained amenorrheic women. Additionally, 
nutritional intake might be inaccurate due to self-report and motivation of subjects to record their 
diet. This may contribute to the inability to accurately address the potential of disordered eating 
and/or specific nutrients/minerals/vitamins in amenorrhea. A 24-hour diet recall and/or food 
frequency questionnaire could be administered in future studies to improve the accuracy of these 
measures. Although none of the women self-reported disordered eating in our study, The Female 
Athlete Triad Questionnaire used to assess and screen for eating disorders was not an ideal 
measurement of eating disorders and body image. There are other questionnaires such as the 
Eating Disorder Examination Questionnaire (EDE-Q) that more accurately project whether an 
individual is at risk or suffers from an eating disorder.  
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In the current study we did not exclude for anemia. It was reported in our study that 
approximately a quarter of the participants had mild anemia, defined as lower than normal 
hemoglobin concentrations or hematocrit values. Anemia is common among young women, thus 
it is not unexpected to find anemic women in this study population [124, 125]. Anemia may 
reduce NO bioavailability as low hemoglobin concentrations may impair NO release and 
therefore, reduce endothelial function [101, 126-129]. Also, anemia can limit oxygen transport 
and negatively affect aerobic performance (i.e. VO2 Max) [125, 130]. When we compared 
anemic women to non-anemic women (when matched for training status and menstrual status) 
both endothelial function and VO2 max were not different. Moreover, there were no associations 
between anemic markers (e.g. low hemoglobin and low hematocrit) and FMD (r = .312, r = -
.027) or VO2 Max (r = -.163, r = .053). Thus, the presence of anemia may not have affected our 
findings on endothelial function and aerobic capacity. Future studies that examine female 
athletes should consider screening for anemia due to its potential effect on NO bioavailability, 
endothelial function and aerobic performance.  
In the current study we did not exclude for oral contraceptive use.  Oral contraceptives 
may positively affect endothelial function in exercise-trained amenorrheic women [12]. The 
effects of oral contraceptives on arterial stiffness in exercise-trained amenorrheic women are 
unknown, however, oral contraceptive use might increase arterial stiffness in young women 
[131]. In an attempt to minimize the effects of and group differences in oral contraceptive use, 
menstrual cycle and oral contraceptive use were tightly controlled. Groups were well matched 
for oral contraceptive use, and women were consistently measured during the placebo phase of 
their oral contraceptive and during the early follicular phase of the menstrual cycle. When we 
compared vascular function between women who used contraception and those who did not use 
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oral contraceptives (in the group as a whole and within each group) we found that FMD, PWV, 
IMT and arterial diameter did not differ.  
Future Directions 
Our findings suggest that vascular dysfunction in exercise-trained amenorrheic women 
may not extend beyond the endothelium. It is necessary to discern potential reasons for 
endothelial dysfunction in amenorrheic women since endothelial dysfunction is not only 
associated with subclinical atherosclerosis but it is also associated with other essential 
physiological responses that are of importance to the female athlete [108-110]. For instance, 
endothelial dysfunction might lead to reductions in exercise capacity [132] because reductions in 
NO can lead to decreased perfusion to the working skeletal muscle [133]. Also reductions in 
endothelial function might reduce muscle force and peak power output [134]. Finally, endothelial 
dysfunction has also recently been linked to repetitive stress/strain injuries, which may be 
common in runners [135]. 
Future investigations should measure estradiol concentrations at different time points of 
the menstrual cycle in order to truly capture the hormonal profile of amenorrhea. Moreover, 
estrogen at the receptor level should be examined.  Studies show that estrogen receptor alpha 
expressed in endothelial cells might influence endothelial function via eNOS activation [136]. If 
circulating estrogen levels cannot explain the decrease in FMD in amenorrhea, it could be that 
estrogen receptors are dysfunctional.  
Additionally, future studies should look into impaired NO cofactors that might be 
responsible for endothelial dysfunction in exercise-trained amenorrheic women. Moreau et al 
suggest that reduced tetrahydrobiopterin (BH4) plays a role in vascular dysfunction in 
postmenopausal women based on the examination that postmenopausal women exhibit reduced 
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FMD [137]. BH4 is an eNOS cofactor that synthesizes NO. A decrease in BH4 can lead to 
increases in oxidative stress and subsequently stiffening of the arteries.  There may be potential 
in this mechanism for amenorrheics who exhibit a similar vascular profile to postmenopausal 
women.  
Conclusion  
In the current study we examined subclinical atherosclerotic CVD in exercise-trained 
amenorrheic women. We found that exercise-trained amenorrheic women had significant 
endothelial dysfunction when compared to their exercise-trained and untrained eumenorrheic 
counterparts. The novel findings of this study are: (1) aortic stiffness is similar in exercise-
trained amenorrheic women and eumenorrheic women, irrespective of training status and (2) 
exercise-trained amenorrheic women had similar favorable vascular remodeling compared to 
exercise-trained eumenorrheic women, manifesting as a larger SFA diameter and smaller IMT 
compared to sedentary eumenorrheic women. The main findings of this study imply that vascular 
dysfunction is not systemic and is restricted to the endothelium. Exercise-associated amenorrhea 
may not alter arterial structure/remodeling in response to chronic/habitual exercise training. It 
should be underscored that amenorrhea and endothelial dysfunction are associated with other 
medical concerns (i.e. decreased bone health, increased risk for stress fractures). In the current 
study the women were young and otherwise healthy individuals so we do not currently know the 
long-term effects of endothelial dysfunction in exercise-trained amenorrheic. Future 
investigations are necessary to examine the mechanisms of endothelial dysfunction in this 
population and long-term clinical consequences with advancing age. 
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Figure and Table Abbreviations 
SBP = Systolic Blood Pressure 
DBP = Diastolic Blood Pressure 
FMD = Flow Mediated Dilation 
PWV = Pulse Wave Velocity  
AUC = Area Under the Curve 
IMT = Intima Media Thickness 
SFA = Superficial Femoral Artery 
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Trained 
Amenorrheic 
(n = 10) 
Trained 
Eumenorrheic 
(n = 18) 
Sedentary 
Eumenorrheic 
(n = 15) 
Probability 
(Main Effect) 
Age (yrs) 21 ± 3.0 22 ± 3.0 23 ± 4.0 0.26 
Total Cholesterol (mg/dL) 161 ± 19.0 166 ± 27.0 175 ± 36.0 0.50 
Triglycerides (mg/dL) 64 ± 17.0 69 ± 29.0 77 ± 40.0 0.57 
Low Density Lipoprotein (mg/dL) 89 ± 18.0 89 ± 22.0 99 ± 30.0 0.52 
High Density Lipoprotein (mg/dL) 66 ± 10.0 64 ± 10.0 65 ± 18.0 0.96 
Glucose (mg/dL) 82 ± 4.0 82 ± 10.0 82 ± 5.0 0.97 
Hematocrit (%) 36 ± 7.0 40 ± 3.0 39 ± 5.0 0.06 
Hemoglobin (g/dL) 13.3 ± 1.0 13.3 ± 0.7 12.7 ± 1.5 0.32 
Brachial SBP (mmHg) 112 ± 6.0 112 ± 8.0 112 ± 4.0 0.99 
Brachial DBP  (mmHg) 69 ± 8.0 72 ± 8.0 72 ± 4.0 0.45 
Resting HR (bpm) 51  ± 11.0 56  ± 9.0 66 ± 9.0*^ 0.00 
Body Fat (%) 18.8 ± 3.9 21.3 ± 4.8* 29.2 ± 4.9*^ 0.00 
Height (cm) 168 ± 6.0 165 ± 6.0 166 ± 9.0 0.39 
Weight (kg) 61.0 ± 7.6 62.2 ± 8.7 65.9 ± 9.6 0.32 
Body Mass Index (BMI) (kg/m2) 21.5 ± 2.0 22.9 ± 2.4 23.9 ± 3.2 0.10 
Lung Volume (L) 3.3 ± 0.2 3.2 ± 0.2 3.2 ± 0.4 0.45 
Lean Body Mass (kg) 49.5 ± 6.1 48.7 ± 5.1 46.4 ± 5.4 0.32 
VO2 Max (ml/kg/min) 50.3 ± 6.7 49.8 ± 3.4* 37.8 ± 5.30*^ 0.00 
Physical Activity Index (PAI)  88.8  ± 17.8 84.7  ± 18.4* 27.9  ± 13.9*^ 0.00 
  
 
 
 
 
 
 
 
  
Table 1: Descriptive Characteristics and Blood Measures 
 
Table 1: A one way ANOVA indicates significant differences between groups on: resting HR, body fat percentage, 
VO2 max test and PAI. Mean ± standard deviations, *^ p < 0.05 significance. *Versus exercise-trained amenorrheic 
women, ^Versus exercise-trained eumenorrheic women 
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Trained 
Amenorrheics 
(n=10) 
Trained 
Eumenorrheics 
(n = 18) 
Sedentary 
Eumenorrheics 
(n= 15) 
Probability 
(Main 
Effect) 
Age of Menarche (yrs) 13 ± 2.00 12  ± 1.00* 12 ± 1.00* 0.04 
17β-Estradiol (pg/ml) 1.66  ± .84 2.22  ± 1.20 2.00 ± .81 0.34 
Gynecological Age (yrs) 7 ± 3.00 9 ± 3.00 11 ± 4.00* 0.05 
Table 2: Menstrual History 
Table 2: A one-way ANOVA indicated significance in the three groups in age of menarche 
and gynecological age. Mean ± standard deviation, *p < 0.05 significance. *Versus exercise-
trained amenorrheic women.   
  
36
Table 3: Arm Hemodynamics 
Trained 
Amenorrheic 
(n = 10) 
Trained 
Eumenorrheic 
(n = 18) 
Sedentary 
Eumenorrheic  
(n = 15) 
Probability 
(Main Effect) 
FMD (%) 7.15 ± 4.21 11.10 ± 4.29 10.25 ± 3.86 0.07 
PWV-Carotid-Radial (m/s) 7.2 ± 1.18 7.6 ± .76 7.9 ± 1.23 0.20 
PWV-Carotid-Femoral (m/s) 5.0 ± 1.00 4.6 ± .51 5.4 ± .76^ 0.03 
PWV-Femoral-Ankle (m/s) 9.1 ± 1.60 9.1 ± 1.50 8.4 ± 1.30 0.36 
Area Under the Curve (aU) 808 ± 350.10 862 ± 311.00 1096 ± 311.30* 0.05 
FMDAUC 6.91 ± 1.33 10.97 ± .98* 10.57 ± 1.11* 0.05 
Mean Brachial Diameter (mm) 3.27 ± .33 3.20 ± .37 3.02 ± .29 0.15 
 
Table 3: A one-way ANOVA indicated that groups were significantly different on carotid-femoral-PWV, FMDAUC, Brachial Shear 
Rate. Mean ± standard deviations, *^p < 0.05 significance. *Versus exercise-trained amenorrheic women, ^versus exercise-trained 
eumenorrheic women 
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Table 4: Leg Hemodynamics 
 
 
 
 
 
Table 4: A one-way ANOVA indicated that groups were significantly different in SFA diameter, average SFA diameter, and diastolic 
SFA IMT. Mean ± standard deviations, *^p < 0.05 significance, *Versus exercise-trained amenorrheic women, ^Versus exercise-
trained eumenorrheic women. 
Trained 
Amenorrheic  
(n = 10) 
Trained 
Eumenorrheic 
(n = 18) 
Sedentary 
Eumenorrheic 
(n = 15) 
Probability 
(Main Effect) 
Systolic SFA Diameter (mm) 5.46  ± .74 5.33  ± .76 4.90  ± .59 0.08 
Diastolic SFA Diameter (mm) 5.70  ± .72 5.68 ± .70 5.10 ± .63^* 0.03 
SFA Diameter (mm) 5.61± .71 5.60 ± .70 5.03 ± .61^* 0.04 
Diastolic SFA IMT (mm) .31  ± .03 .35  ± .06 .38  ± .07* 0.01 
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Trained 
Amenorrheic 
 (n= 10) 
Trained 
Eumenorrheic 
(n=18) 
Sedentary 
Eumenorrheic  
(n =15) 
     P-
Value   
(Main 
Effect) 
Total Calories 1900.40 ± 497.81 1596.67  ± 411.74 1483.13  ± 452.74 0.08 
Protein (g/d) 87.50  ± 22.61 72.33  ± 16.54 62.13  ± 13.99* 0.00 
Carbohydrate (g/d) 239.00  ± 75.22 203.22  ± 70.68 176.20  ± 71.72 0.10 
Dietary Fiber (g/d) 23.80  ± 8.15# 21.17  ± 9.61# 18.67  ± 7.62# 0.35 
Total Fat (g/d) 34.00  ± 3.62 32.89  ± 5.99 35.93  ± 5.82 0.29 
Saturated fat (g/d) 11.00  ± 2.31 11.00  ± 3.91 11.20  ± 2.68 0.98 
Monounsaturated Fat (g/d) 13.00  ± 2.49 12.28  ± 2.80 13.73  ± 2.79 0.32 
Polyunsaturated Fat (g/d) 7.50  ± 1.51 6.67  ± 2.22 8.00  ± 2.33 0.20 
Linoleic Acid (g/d) 14.40  ± 5.27 10.83  ± 5.04# 11.93  ± 5.12# 0.21 
Alpha Linoleic Acid (g/d) 1.21  ± .57 1.03  ± .63# 1.25  ± .45 0.50 
Omega-3 EPA (mg/d) 36.60  ± 75.71 11.06  ± 11.64 12.07  ± 10.93 0.19 
Omega-3 DHA (mg/d) 83.70 ± 131.52 32.94 ± 28.51 36.33 ± 31.86 0.14 
Cholesterol (mg/d) 249.70 ± 110.21 260.28 ± 154.14 195.00 ± 81.363 0.30 
Calcium (mg/d) 913.30 ± 234.48# 787.78 ± 373.25# 687.93 ± 217.49# 0.19 
Potassium (mg/d) 2891.40 ± 688.42# 2298.83 ± 785.63# 2149.80 ± 739.33*# 0.05 
Sodium (mg/d) 2471.90 ± 495.45 2365.17 ± 689.21 2313.07 ± 836.95 0.86 
Copper (ųg/d) 1555.20 ± 591.80 1373.56 ± 851.96 1053.20 ± 406.97 0.17 
Iron (mg/d) 15.10 ± 4.41# 14.22 ± 5.43# 12.00 ± 2.85# 0.19 
Magnesium (mg/d) 373.20 ± 140.75 291.17 ± 102.51# 255.73 ± 100.74*# 0.04 
Phosphorous (mg/d) 1410.20 ± 320.88 1132.72 ± 281.31* 1020.40 ± 240.20* 0.01 
Selenium (ųg/d) 112.50 ± 28.87 96.06 ± 26.81 92.2 ± 26.73 0.18 
Zinc (mg/d) 11.20 ± 3.68 9.78 ± 2.51 8.00 ± 2.42* 0.02 
Vitamin A (ųg RAE) 822.30 ± 378.17 894.89 ± 899.46 585.60 ± 242.33# 0.37 
Table 5: Dietary Record Information 
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Vitamin B6 (mg/d) 3.06 ± 1.92 2.09 ± .92 1.77 ± .62* 0.03 
Vitamin B12 (ųg/d) 4.48 ± 3.11 3.89 ± 1.88 3.14 ± 2.33 0.37 
Vitamin C (mg/d) 99.80 ± 41.10 103.67 ± 74.41 89.53 ± 58.53 0.81 
Vitamin D (ųg/d) 3.80 ± 3.16# 2.39 ± 1.85# 2.47 ± 1.64# 0.22 
Vitamin E (mg AT) 12.30 ± 8.50# 9.17 ± 6.11# 8.60 ± 4.95# 0.34 
Vitamin K (ųg/d) 113.80 ± 64.91 285.44 ± 720.04 149.60 ± 138.64 0.59 
Folate (ųg DFE) 556.40 ± 263.86 504.22 ± 222.66 510.00 ± 192.68 0.83 
Thiamin (mg/d) 1.50 ±  .31 1.35 ±  .50 1.28 ±  .34 0.42 
Riboflavin (mg/d) 2.34 ±  .79 1.75 ±  .51* 1.49 ±  .36* 0.00 
Niacin (mg/d) 27.00 ± 7.45 20.50 ± 6.62* 19.07 ± 4.25* 0.01 
Choline (mg/d) 316.30 ± 84.55# 273.61 ± 78.08# 250.16 ± 55.85*# 0.01 
 
Table 6: A one-way ANOVA indicated that protein, potassium, magnesium, phosphorous, zinc, vitamin B6, 
Riboflavin, Niacin, Choline were significantly different between groups. Mean ± standard deviation, *p < 0.05 
significance; *versus exercise-trained amenorrheic women, #Nutrient, mineral or vitamin deficiency based on 
Dietary Guideline for Americans, 2010.   
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Table 7: Pearson’s Bivariate Correlations 
 
 
 
 
 
 
 
 
 
 
 
Table 7: Pearson’s Bivariate Correlations between Estrogen, FMD, PWV, Mean SFA 
Diameter, SFA IMT, Body Fat, VO2 Max. *p < 0.05 significance. 
 
 
 
 
 
 
 
 
 
 
 
 
  Estrogen  FMD PWV 
SFA 
Diameter 
SFA 
IMT 
Body 
Fat 
FMD -.001      
PWV -.109 .025     
SFA Diameter .013 -.127 -.203    
SFA IMT .034* .283 .186 -.113  
Body Fat  -.264 .242 -281 -.205 -.264  
VO2 Max .228 -.208 -.417
*
 
-.303 .228 -.779* 
Figure 1: A one way ANOVA indicated that 
trained amenorrheic women compared with the 
deviations, *p < 0.05 significance. *
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FMDAUC (mm) was significantly lower in exercise
eumenorrheic counterparts, Mean
Versus exercise-trained amenorrheic.
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Figure 2: A one way ANOVA indicated that PWV
exercise-trained eumenorrheic women compared with sedentary eumenorrheic women across 
groups, Mean ± Standard Deviations
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-Carotid Femoral was significantly lower in 
, ^p < 0.05 significance. ^Versus exercise
Eumenorrheic. 
Trained Eumenorrheics Sedentary Eumenorrheics
Carotid-Femoral PWV
^
 
 
-trained 
 Figure 3: A one-way ANOVA indicated that exercise
women had a significantly larger diastolic d
eumenorrheic women. Mean ± Standard Deviations, *
trained Amenorrheic;
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-trained amenorrheic and eumenorrheic 
iameter (mm) compared with sedentary 
^p < 0.05 significance; *Versus exercise
^Versus exercise-trained Eumenorrheic. 
Trained Eumenorrheics Sedentary Eumenorrheics
SFA Diastolic Diameter (mm)
*
 
 
-
^
Figure 4: A one-way ANOVA indicated that the 
trained amenorrheic women compared with sedentary 
Deviations, *p < 0.05 significance. *Versus exercise
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SFA IMT was significantly smaller in exercise
eumenorrheics, Mean
-trained Amenorrheic
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APPENDIX 1 
 
EXERCISE SCIENCE 
820 COMSTOCK AVENUE 
201 WOMEN’S BUILDING 
SYRACUSE, NY 13210 
(315)-443-2114 
 
EXERCISE ASSOCIATED AMENORRHEA AND ARTERIAL STIFFNESS IN ENDURANCE-TRAINED 
FEMALES 
 
 
Principal Investigator: Kevin Heffernan, Ph.D. 
Telephone: 315-443-9801 
Email: ksheffer@syr.edu 
IRB Protocol #: 12-316 
 
My name is Jacqueline Augustine and I am a Graduate Student at Syracuse University working 
with Dr. Kevin Heffernan. We are inviting you to participate in a research study. Involvement in 
the study is voluntary, so you may choose to participate or not to participate. This sheet will 
explain the study to you and please feel free to ask questions about the research if you have any. 
I will be happy to explain anything in detail if you wish.  
Purpose 
We are interested in learning more about the artery health in females across fitness levels and 
menstrual statuses. Exercise is widely beneficial to the arteries and has been shown to prevent 
the risk of cardiovascular disease. Many women who regularly exercise experience menstrual 
cycle irregularities and therefore it is of interest to us if this affects their risk for cardiovascular 
disease. Therefore, we are also interested in how the menstrual cycle influences arterial health. 
Amenorrhea is defined as a lack of menstrual cycle and often occurs in women who regularly 
exercise and/or are endurance trained. We wish to examine if endurance trained amenorrheic and 
eumenorrheic females have altered vascular function.  
Who can participate? 
• Women between the ages of 18-30 without a history of high blood pressure, thyroid 
disorder, heart disease, diabetes, are not pregnant and currently do not smoke.   
Do I have to participate? 
• Your participation in this study is voluntary, which means you get to decide whether or 
not you want to participate 
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• Make sure that you read this entire form before making a decision and take as much time 
as you need.  
• Feel free to ask as many questions about the study as you want. If you do not understand 
a term in the form, ask, and a researcher will explain it for you. 
• If you decide to participate in the study you will be asked to sign a consent form. 
• Do not sign the consent form until all of your questions have been answered and you 
understand what will happen in the study. 
• Your signature means that you agree to participate in this study. 
• You can ask for a copy of this form whether or not you agree to take part in the study. 
• Your decision not to be in this research study will not result in any loss of benefits to 
which you are otherwise entitled. 
Can I Withdraw From The Study Once It Has Started? 
• At any time you may remove yourself from the study without giving any reason.  
• If you are a student, withdrawing from the study will not affect your grade in courses in 
any way.  
What Can I Expect From Participating?  
For this study, you will need to visit the Human Performance Laboratory located in the Women’s 
Building at Syracuse University once. When you visit the lab, we will ask you to come first thing 
in the morning on an empty stomach (so no eating since the previous night).  You will be asked 
to fill out and sign this consent form, Health History Questionnaire, Female Athlete Triad 
Questionnaire. You may be asked to perform a pregnancy test (over the counter urine test). You 
will bring with you your dietary 3-day diary and we will discuss this and do a 24 hour recall in 
which you will recall all you have had to eat in the last 24 hours. You will then be asked to lie 
down and rest for 10 minutes.  Following rest, we will check your cholesterol and blood sugar, 
hemoglobin and hematocrit by obtaining a very small drop of blood from your fingertip.  We 
will measure your blood pressure using a machine that inflates/deflates a small cuff around your 
wrist.  Following this we will check your artery stiffness.  To do this, we will use a very sensitive 
blood pressure machine that looks like a pen with a little watch battery at the end.  We will place 
this pen on top of your skin over your wrist, neck and upper leg.  From these measurements, we 
can determine how stiff your arteries are.  This measurement is non-invasive (no needles/no 
blood) and will only take a few minutes.  We will then use the ultrasound to look at your brachial 
arm artery and femoral/upper leg artery. The arm artery will be examined before and after a 
blood pressure cuff is inflated for 5 minutes on your forearm (non-invasive, no needles/no 
blood). This might be uncomfortable, as it will feel tight, like when the doctor takes your blood 
pressure at the doctor’s office, but does not pose any risk and will not be done on your leg artery. 
This is meant to examine how well your arteries respond to the stress of increased blood flow 
(endothelial function).  The ultrasound probe placed on your leg artery will feel cold and the 
measurement itself will be very quick. This will give us important information on how your 
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arteries may also change in a trained or not trained state. You will then give us a salivary sample 
to measure hormones (used only for research purpose not for clinical purposes), have your body 
fat percentage measured in the BodPod and perform a Maximal fitness level test, also known as a 
VO2Max testing protocol on the treadmill. In which you will run until exhaustion to determine 
your fitness level.  
Visit 1 Outline:  
• You will be asked to sign a consent form 
• You will fill out a health history, physical activity questionnaire, female athlete triad 
questionnaire 
• Prior to this visit upon scheduling you will be sent ample information regarding a 3-day 
dietary analysis in which you will fill out your diet over the course of 3 days. You will be 
asked to bring this with you and this will be discussed at the time of your visit, with a 24-
hour recall. You will be given interesting information regarding your diet. 
• Female participants will be asked the following questions (which will be asked and 
detailed on the health history questionnaire): When was your last menstrual cycle? Are 
you asexually active? If so, do you use a method of birth control? Which type and how do 
you use this type of birth control? [i.e. hormonal form (Depo-Provera) and method 
(continuous birth control)]. If you take the oral contraceptive pill do you skip the 
placebo/withdrawal pills? (All detailed on the health history questionnaire). If their last 
menstrual cycle was greater than 28 days then a pregnancy test will be administered. In 
addition to these questions all female subjects will be asked to provide a urine sample to 
be tested via an over the counter pregnancy test. Any subjects with a positive result will 
also be disqualified and deemed ineligible from study participation. If present a positive 
pregnancy result participants will also be suggested to see their health care provider 
• Your arterial stiffness and endothelial function will be measured.  
• Blood Lipids, Hematocrit, Hemoglobin will be measured via a finger stick.  
• We will measure your hormones (estrogen) via a salivary drool sample. This will take 
approximately 10 minutes at the most.  This measurement of estrogen levels is only for 
research purposes not for clinical and/or diagnostic purposes.   
• You will have your body fat measured using the Bod Pod.  For this measurement, you 
will be required to wear a bathing suit (but don’t worry, there’s no water involved; you 
will not get wet).  You will be asked to sit in a chamber that resembles a giant egg for 10 
minutes.  This machine measures your volume to calculate body fat.   
• Aerobic capacity (Maximal Fitness Level) VO2Max test.  You will be supervised during all 
exercise testing.  
• This session will take approximately 2-3 hours 
 
What Benefits Can I Expect From Participating?  
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• A benefit from this study is helping us understand the potential health benefits of 
endurance exercise to improve artery health
 
• You may feel good about helping others by participating 
• You will receive information on your body fat, cholesterol, blood pressure, hematocrit, 
hemoglobin, fitness level (VO2Max) and diet.  
• These tests are not being used to diagnose a problem.  But if you do have high blood 
pressure, high cholesterol or are close to anemia values in hemoglobin content we will 
inform you to go the university health center or go see your family physician.  
 
Are There Any Potential Risks From Participating In This Study? 
• There are no more than minimal risks (risks encountered in everyday life) associated with 
this study.  
• There is possible discomfort with the 5-minute inflation of the blood pressure cuff to 
measure endothelial function. 
• You may experience discomfort from the finger stick to test your blood lipids, 
hematocrit, and hemoglobin.  This will only be done twice or three times and no more 
than that and we will use different fingers each time to reduce discomfort. If desired, we 
can also place ice on the finger prior to the finger stick to reduce discomfort from the 
pinch.   
• There is a small risk of infection associated with the finger stick.  However we will 
reduce this risk by ensuring that everything we use is clean and sterile.  
• There is also discomfort associated with arterial stiffness or leg blood blow 
measurements. Ultrasound gel may seem cool and tingly on the skin but that is it.   
• There may be abnormal changes in heart rate and blood pressure associated with exercise. 
These abnormal changes are very rare and you will be asked to report any abnormal 
feelings throughout the exercise sessions. The research team will constantly be 
monitoring heart rate and blood pressure. We will also instruct you on proper breathing to 
help reduce this risk. 
• There is also risk of injury and muscle soreness from the exercise protocol. All exercise 
sessions will be directly supervised to reduce risk for injury.  Ensuring that you 
communicate with the researcher throughout the protocol will reduce risks. A proper cool 
down is also set it place for each participant. If at any point you are uncomfortable or feel 
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pain anywhere, please tell us immediately.  If this occurs you will stop the protocol and 
not have to continue.  
• A risk to participation in this study is the uncovering of a potential eating disorder, 
presence of amenorrhea, and/or the presence of stress. Information about your health may 
be revealed to you that you were not already aware of. The Health History Questionnaire 
includes a detailed Menstrual Status Questionnaire that might define you as being 
amenorrheic. Likewise, the Female Athlete Triad Questionnaire might screen you 
positive for an eating disorder or stress. In either scenario you will be given ample 
resources that are provided to you at the end of this consent form. However, we are not 
diagnosing you and all of our methods are only being used for research purposes.  
Are There Any Costs? 
• There will be no costs to you for participating in this study. 
Who Can See Information About This Study? 
• The research records from this study will be confidential. Confidentiality means that it is 
our responsibility to keep any information you provide private and safe. 
• Only members of the trained research staff for this study may look over your research 
records. 
• The paperwork, results and records will be kept in a locked filing cabinet that only the 
researchers will have access to.  
• All information stored on computers requires a password access it.  Only members of the 
research team will have this password.  
• The data and research record will be stored for up to 10 years.  
• Your individual results will not be used in any way (we will average all results and 
display group averages only when presenting findings in papers and presentations) 
What Are My Rights In This Study? 
• Your participation in this study is voluntary.  
• If at any point you wish to withdraw yourself from the study you may.  
• You do not give up any of your legal rights by participating in this study. 
 
In Case Of Injury: 
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• In the event of illness or physical injury resulting from taking part in this research study, 
medical treatment will not be compensated for and you will be responsible for any costs 
not paid by your insurance company. No other compensation is offered by Syracuse 
University.  However, treatment can be sought at Syracuse University or University 
Hospital. Syracuse University has no plans to give you money if you are injured. You 
have not waived any of your legal rights by signing this form. 
Resources:  
• For Syracuse University students, employees and faculty, these resources will be: 
Syracuse University Health Services (315-443-9005), Syracuse University Academic 
Services (315-443-2506), Syracuse University Counseling Services (315-443-4715) and 
their Health Care Provider. For those participants that may not be Syracuse students, 
faculty or employees and are not comfortable with these resources provided will be 
referred to see their Health Care Provider if they are not already seeing them.  
 
Who Can I Contact For Questions Or More Information? 
• If you have any questions, concerns, exercise related injuries or complaints about this 
study at any time, please feel free to contact: 
• Jacqueline Augustine at Jaimse@syr.edu or call her cell-phone at 860-508-8996. 
• Dr. Kevin Heffernan at ksheffer@syr.edu or call his office at 315-443-9801. 
• If you cannot reach Dr. Heffernan or Jacqueline or you would like to speak to someone 
else about any questions, concerns, complaints, or your rights as a participant in this 
study, you can call the Syracuse University Institutional Review Board (IRB) at 315-443-
3013 
 
 
 
If you do not want to take part in the protocol, you have the right to refuse to take part, without 
penalty. If you decide to take part and later no longer wish to continue, you have the right to 
withdraw from the study at any time, without penalty.  
By signing below you indicate that you have read and fully understood this informed consent 
form. You are fully aware of the purpose and procedures of this study as well as the risks, 
discomforts, and benefits associated with the experimental protocol and that you sign this 
document freely and voluntarily.  
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All of my questions have been answered, I am 18 years of age or older, and I wish to participate 
in this research study. I have received a copy of this consent form.  
 
_________________________________________    _________________________ 
Signature of participant                                                                          Date  
 
_______________________________________     
Printed name of participant     
                                                                    
_________________________________________    _________________________ 
Signature of researcher                                                                   Date  
 
_________________________________________     
Printed name of researcher           
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APPENDIX 2 
 
Paffenbarger Physical Activity Questionnaire 
 
 
SUBJECT ID: _________________         Date: ______________ 
 
Birth date: ___________ Male/Female_______ Age: ______ 
 
 
PLEASE ANSWER THE FOLLOWING QUESTIONS BASED ON YOUR AVERAGE 
DAILY PHYSICAL ACTIVITY HABITS FOR THE PAST YEAR 
 
1. How many stairs did you climb up on an average day during the past year? 
__________ stairs per day (1 flight or floor=10 stairs) 
 
2. How many city blocks or their equivalent did you walk on an average day during the past 
year? 
_______________ blocks per day (12 blocks = 1 mile) 
 
3. Do you run or cycle? (circle one). If so how many miles a week 
?_________________________ 
 
4. List any sports, leisure, or recreational activities you have participated in on a regular basis 
during the past year. Enter the average number of times per week you took part in these activities 
and the average duration of these sessions. Include only time you were physically active (that is, 
actual playing or activity time). 
 
Sport or Recreation 
 
Times per 
Week 
Hours per 
day  
Minutes per  
day 
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5. On a usual weekday and a weekend day, how much time do you spend on the following 
activities? 
 
Sport or Recreation 
 
Usual weekday 
Hours/Day 
Usual weekend 
Hours/Day  
a. Vigorous activity (digging in the garden, 
strenuous sports, jogging, aerobic dancing, 
sustained swimming, brisk walking, heavy 
carpentry, bicycling on hills, etc.) 
 
  
b. Moderate activity (housework, light 
sports, regular walking, golf, yard work, 
lawn mowing, painting, repairing, light 
carpentry, ballroom dancing, bicycling on 
level ground. Etc.) 
 
  
 
c. Light activity (office work, driving car, 
strolling, personal care, standing with little 
motion, etc.) 
  
d. Sitting activity (eating, reading, desk 
work, watching TV, listening to radio, etc.) 
 
  
e. Sleeping or reclining 
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APPENDIX 3 
PHYSICAL ACTIVITY INDEX 
 
Evaluate your current exercise program by selecting your score for each category. 
 
 Score Activity 
Intensity   
 5 Sustained heavy breathing and perspiration 
 4 Intermittent heavy breathing and perspiration, 
as in tennis 
 3 Moderately heavy, as in cycling and other 
recreational sports 
 2  Moderate, as in volleyball, softball 
 1 Light, as in fishing 
Duration 
  
 4 Over 30 minutes 
 3 20 to 30 minutes 
 2 10 to 20 minutes 
 1 Less than 10 minutes 
Frequency   
 5 6 to 7 times per week 
 4  3 to 5 times per week 
 3 1 to 2 times per week 
 2  A few times per month 
 1  Less than once a month 
 
Intensity X Duration X Frequency = Score Total 
Your Score:  _______________  x  _______________  x  ___________  =  _______________  
 
Evaluation of Activity Score 
Score Evaluation Activity Category 
81 to 100 Very active lifestyle High 
60 to 80 Active and healthy Very good 
40 to 59 Acceptable but could be better Fair 
20 to 39 Not good enough Poor 
Under 20 Sedentary  
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APPENDIX 4 
 
SELF-ADMINISTRATED PRE-EXERCISE MEDICAL HISTORY FORM 
 
All information given is confidential.  It will enable us to better understand you and your 
health and fitness habits.  
To ensure that you do not meet any of the exclusion criteria, you must answer all the 
questions included here. 
 
SUBJECT ID._______________________________Date:______________ 
 
Birth date:_______________ 
 
Male/Female   Age: ______ 
 
 
Health History Questionnaire 
           Yes No 
1. Do you ever get chest pains while at rest and / or during exertion?   ____ ____ 
 
2. If the answer to question 1 is “yes”, has a physician diagnosed these pains? 
 
3. Have you ever had a heart attack or been told of any problems with your heart? ____    ____ 
      
4. If the answer to question 3 is “yes”, was your heart attack within the last year? ____    ____ 
 
5. Have you ever had an echocardiogram?  If yes, when?    ____ ____ 
 
6. Do you have high blood pressure (i.e., a reading of more than 140 / 90) ?  ____ ____ 
 
7. If the answer to question 4 is “yes” is your high blood pressure currently  
being treated by medication (e.g., “water pills”) ?     ____ ____ 
 
8. Have you ever been diagnosed with high cholesterol?    ____ ____ 
 
9. Do you lose your balance because of dizziness or do you ever lose 
consciousness?         ____ ____ 
 
10. Has your physician ever specifically told you not to do “heavy” or “hard”  
exercise?          ____ ____ 
 
11. Have you been diagnosed with any of the following: 
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o Diabetes Mellitus         ____ ____ 
 
o Rheumatoid Arthritis        ____ ____ 
 
o Bleeding disorder         ____ ____ 
Medical History 
 
Do you have or have you ever had:  (check if yes) 
 
____ heart murmur     _____ arthritis 
____ extra/skipped heart beats   _____ asthma 
____ chest pain or pressure    _____ bronchitis 
____ high blood pressure    _____ cancer 
____ heart attack     _____ diabetes 
____ stroke      _____ emphysema 
 
 
Medical History (continued) 
 
Do you have or have you ever had:  (check if yes)    
____ leg cramps     _____ epilepsy 
____ varicose veins     _____ pneumonia 
____ dizziness/fainting    _____ rheumatic fever 
____ back pain     _____ scarlet fever 
____ shortness of breath    _____ surgery 
____ injuries to back, knees, ankles 
 
Explanations/Commments/Descriptions:_________________________________ 
 
________________________________________________________________ 
 
Other diseases/injuries/medical problems: ________________________________ 
 
_________________________________________________________________ 
 
Medicines/Drugs you are now taking(please list dosages):____________________ 
 
_________________________________________________________________ 
 
 
 
Family History 
 
Please indicate the number of blood relative (mother, father, grandparents, siblings who have 
or have had the following: 
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 Heart attack or stroke before age 50   _______ 
 Heart attack or stoke after age 50   _______ 
 Congenital heart disease    _______ 
 Heart operations     _______ 
 High blood pressure     _______ 
 Diabetes      _______ 
 Substantially overweight    _______ 
 High cholesterol levels    _______ 
 
Remarks:___________________________________________________________ 
 
Present Symptoms Review 
 
Do you ever experience any of the following during exercise? 
 
______ Chest pain 
______ Shortness of breath 
______ Heart palpitations 
______ Cough on exertion 
 
Health Inventory 
 
Smoking Habits 
 
Do you smoke cigarettes at present?  Yes ______   No _____ 
 If yes, how many per day?  <1/2 pack ______  1/2 to 1 pack _____ 
      1 - 2 packs _______  >2 packs _____ 
 
Did you smoke cigarettes in the past and quit permanently?  Yes _____  No ______ 
 
 How may years has it been since you quit?      ________ 
 How many packs per day were you smoking before you quit?   ________ 
 How many years did you smoke before you quit?     _______ 
 
 
 
  Menstrual Status  
 
At what age did you have your first menstrual period? ___________ 
 
What was the date of your last menstrual period?______________ 
 
Have you ever been amenorrheic (only 1-2 periods in a year)? __________ 
 If yes, for how long? ___________ 
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If your last menstrual cycle was greater than 28 days ago and/or you have a history of 
amenorrhea are you currently under the care of a health care provider? ___________ 
 
Do you currently experience a menstrual cycle? ____________ 
 
Have you ever had any skipped menses, if yes how many? _________________ 
 
Do you use oral contraceptives? ________Which kind? ____________________ What 
dose?______ If yes, for how long? ____________ 
Do you take the withdrawal/Placebo pills?___________ 
  
Do you use Depo-Provera for birth control? _________If yes, for how long have you used 
this?_________ 
 
How many periods in a year do you have? __________ 
 
About how many days are there between periods? ___________ 
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APPENDIX 5 
 
The Female Athlete Triad Questionnaire 
Circle Yes or No  
 
1. Do you worry about your weight or body composition?                                             
 
Yes      No  
 
2. Do you limit or carefully control the foods that you eat?  
 
Yes       No  
 
3. Do you try to lose weight to meet weight or image/appearance requirements in  
 
your sport?  
 
Yes       No  
 
4. Does your weight affect the way you feel about yourself?  
 
Yes      No  
 
5. Do you worry that you have lost control over how much you eat? Yes      No  
 
6. Do you make yourself vomit, use diuretics or laxatives after you eat?  
 
Yes      No  
 
7. Do you currently or have you ever suffered from an eating disorder?  
 
Yes     No  
 
8. Do you ever eat in secret?  
 
Yes     No  
 
9. What age was your first menstrual period?  
 
Yes     No  
 
10.Do you have monthly menstrual cycles?  
 
Yes     No  
 
11.How many menstrual cycles have you had in the last year?  
  
60
 
Yes     No  
 
12.Have you ever had a stress fracture?  
 
Yes     No 
 
Please circle the response that best matches your situation.  
Never= 1  Rarely=2  Occasionally=3  More often than not=4  
Regularly= 5  Always=6  
 
1. Do you want to weigh more or less than you do?                                    1   2   3   4   5   6  
 
2. Do you lose weight regularly to meet weight requirements for your sport?        1   2   3   4   5   
6  
 
      How do you do it?________________________________________________  
 
3. Is weight/body composition an issue for you?                                        1   2   3   4   5   6  
 
4. Are you satisfied with your eating habits?                                                 1   2   3  4   5   6  
 
5. Do you think your performance is directly affected by your weight? 1   2   3   4   5   6  
 
      If so how?_____________________________________________  
 
6. Do you have forbidden foods?                                                                      1   2   3   4   5   6                               
 
7. Are you a vegetarian?                                                                                     1   2   3   4   5   6  
 
Since what age?_________________________________________  
 
8. Do you miss meals?                                                                                         1   2   3   4   5   6  
 
If so, how often? For what reason?__________________________  
 
9. Do you have rapid increases of decreases in your body weight?       1   2   3   4   5   6 10. What 
do you consider your ideal competitive weight?                       1   2   3   4   5   6  
 
11. Has anyone ever suggested you lose weight or change your eating habits?         
1   2   3   4   5   6  
 
12. Has a coach, judge, or family member ever called you fat?                1   2   3   4   5   6  
 
13. What do you do to control your weight?___________________________  
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      ___________________________________________________________                                      
 
14. Do you worry if you have missed a workout?                                        1   2   3   4   5   6  
 
15. Do you  exercise or are you physically active as well as training for your sport?   
1   2   3   4   5   6  
 
16. Do you have stress in your life outside of sport?                                 1   2   3   4   5   6  
 
     What are these stresses?_______________________________________  
 
17. Are you able to cope with stress?                                                              1   2   3   4   5   6  
 
     How?_______________________________________________________  
 
18. What is your family structure?____________________________________  
 
19. Do you use or have you use(d) these ways to lose weight?   
 
a. laxatives                                                                                          1   2   3   4   5   6  
 
b. diuretics                                                                                          1   2   3   4   5   6  
 
c.  vomiting                                                                                         1   2   3   4   5   6  
 
d. diet pills                                                                                          1   2   3   4   5   6  
 
e.  saunas                                                                                           1   2   3   4   5   6  
 
f. plastic bags or wrap during training                                                  1   2   3   4   5   6  
 
g. other methods(please state)________________________________     1   2   3   4   5   6  
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APPENDIX 6 
 
Three Day Food Log  
 
1. Please write down everything you eat and drink for 3 typical days. Try to include at  least one 
weekend day - Saturday or Sunday.  
 
2. Record this in the column marked FOOD and BEVERAGES.    
 
3. Record only amounts EATEN, not amount served.  
 
4. Record the brand name and method of cooking in the “METHOD OF PREPARATION / 
BRAND NAME” column.    
 
5. Under ‘AMOUNT’, record in ‘teaspoons’, ‘cups’, or fractions of these. You may use ‘slices’ 
or ‘pieces’ when necessary. If something eaten has a specific measurement on the label, record 
that amount.  For example: Coke - 12 ounce can, Hershey bar 1.45 ounces.  
 
6. It is important to remember the following while recording different types of food:  
 
 Milk:  State if whole, skim, fortified, powdered, liquid, evaporated, or chocolate  
 
 Liquids:  Record amount of milk and all beverages in ‘cups’ or ‘ounces’.   
 
 Bread:  Specify white, rye, whole wheat, raisin, etc.  
 
 Meats: Give the length, width and thickness of the portion, or its weight in ‘ounces’   
after cooking.   
 
 Cereals, rice, and pasta:  Record amount of cereals, rice, and pasta in ‘cups’ or 
fractions of cup. Do not record in ‘BOWLS’.   List anything added e.g. fruit, sugar  
 
 Fruits and Vegetables:  Specify, fresh, frozen, canned, dried, or freeze dried.  
 
 Condiments: Record any jelly, butter, ketchup, mayonnaise or seasonings added.  
 
 Canned foods: Record what food is packed in – oil, water, syrup, etc 
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